Drawing for RUBIUS THERAPEUTICS

USPTO serial 87287699

RUBIUS THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 6158400Status 700Renewal
Filing date
Status date
Registration date
Sep 22, 2020
Examiner
VALLILLO, MELISSA C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RUBIUS THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi, Esq.

Christina M. Licursi, Esq. Wolf, Greenfield & Sacks, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210-2206UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, central nervous system diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disordersACTIVEOct 15, 2019
042scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticalsACTIVEDec 9, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 22, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 19, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 18, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 17, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 10, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 10, 2020EX3GSOU EXTENSION 3 GRANTED—
Feb 26, 2020IUAFUSE AMENDMENT FILED—
Feb 26, 2020EXT3SOU EXTENSION 3 FILED—
Feb 26, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 27, 2019EX2GSOU EXTENSION 2 GRANTED—
Aug 27, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 23, 2019EXT2SOU EXTENSION 2 FILED—
Aug 23, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2019EX1GSOU EXTENSION 1 GRANTED—
Feb 25, 2019EXT1SOU EXTENSION 1 FILED—
Feb 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 6, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 6, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 28, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 3, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 3, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 13, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 29, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 29, 2018XAECEXAMINER'S AMENDMENT ENTERED—
May 29, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 29, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
May 29, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
May 3, 2018GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
May 3, 2018GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
May 3, 2018CNCFACTION CONTINUING A FINAL - COMPLETED—
May 2, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 2, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 2, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 4, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 4, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 4, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 2017ALIEASSIGNED TO LIE—
Sep 26, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2017DOCKASSIGNED TO EXAMINER—
Jan 12, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance